Clinical Trials Directory

Trials / Terminated

TerminatedNCT01276249

The STAPLE International Post-Market Registry

The STAPLE-International Post-Market Registry

Status
Terminated
Phase
Study type
Observational
Enrollment
108 (actual)
Sponsor
Medtronic Cardiovascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Aptus Endosystems STAPLE International Post-Market Registry is intended to expand the clinical knowledge base by including 'real world' subjects.

Detailed description

The Aptus Endosystems STAPLE International Post-Market Registry is intended to expand the clinical knowledge base by including 'real world' subjects. All subjects diagnosed with a qualifying AAA suitable for elective endovascular repair, who meet the inclusion/exclusion criteria for the registry, are eligible for enrollment and should be offered informed consent to participate.

Conditions

Interventions

TypeNameDescription
DEVICEFortevo EndograftThe Fortevo Endograft, Main Body and Iliac Lumen Delivery System are indicated for the endovascular treatments of patients with infrarenal abdominal aortic aneurysms or aortic-iliac aneurysms having suitable morphology for endovascular repair.

Timeline

Start date
2010-08-01
Primary completion
2015-04-01
Completion
2015-06-19
First posted
2011-01-13
Last updated
2021-11-02

Locations

9 sites across 6 countries: Canada, Germany, Greece, Italy, Netherlands, Spain

Source: ClinicalTrials.gov record NCT01276249. Inclusion in this directory is not an endorsement.